Cold Case of Thrombolysis: Cold Recombinant Tissue Plasminogen Activator Confers Enhanced Neuroprotection in Experimental Stroke

BACKGROUND: Thrombolysis and endovascular thrombectomy are the primary treatment for ischemic stroke. However, due to the limited time window and the occurrence of adverse effects, only a small number of patients can genuinely benefit from recanalization. Intraarterial injection of rtPA (recombinant...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Yuyou, Gu, Shanshan, Han, Ziping, Yang, Zhenghong, Zhong, Liyuan, Li, Lingzi, Wang, Rongliang, Yan, Feng, Luo, Yumin, Borlongan, Cesario, Lu, Jie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10547350/
https://www.ncbi.nlm.nih.gov/pubmed/37655472
http://dx.doi.org/10.1161/JAHA.123.029817

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10547350/
https://www.ncbi.nlm.nih.gov/pubmed/37655472
http://dx.doi.org/10.1161/JAHA.123.029817

Ejemplares similares